[go: up one dir, main page]

ATE251215T1 - Helicobacter felis impfstoff - Google Patents

Helicobacter felis impfstoff

Info

Publication number
ATE251215T1
ATE251215T1 AT01202666T AT01202666T ATE251215T1 AT E251215 T1 ATE251215 T1 AT E251215T1 AT 01202666 T AT01202666 T AT 01202666T AT 01202666 T AT01202666 T AT 01202666T AT E251215 T1 ATE251215 T1 AT E251215T1
Authority
AT
Austria
Prior art keywords
subunit polypeptides
helicobacter felis
nucleic acid
acid sequences
vaccines
Prior art date
Application number
AT01202666T
Other languages
English (en)
Inventor
Johannes Gerardus Kusters
Giovanni Cattoli
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE251215T1 publication Critical patent/ATE251215T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01202666T 2000-07-17 2001-07-11 Helicobacter felis impfstoff ATE251215T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00202565 2000-07-17

Publications (1)

Publication Number Publication Date
ATE251215T1 true ATE251215T1 (de) 2003-10-15

Family

ID=8171823

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01202666T ATE251215T1 (de) 2000-07-17 2001-07-11 Helicobacter felis impfstoff

Country Status (10)

Country Link
US (1) US7514547B2 (de)
EP (1) EP1176192B1 (de)
JP (1) JP2002355054A (de)
AT (1) ATE251215T1 (de)
AU (1) AU782172B2 (de)
CA (1) CA2351110A1 (de)
DE (1) DE60100879T2 (de)
DK (1) DK1176192T3 (de)
ES (1) ES2208519T3 (de)
PT (1) PT1176192E (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102078622A (zh) * 2004-08-13 2011-06-01 巴里.J.马沙尔 细菌递送系统
US8029777B2 (en) 2004-08-13 2011-10-04 Marshall Barry J Helicobacter system and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
WO1995014093A1 (en) * 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
US5610060A (en) * 1994-06-24 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Isolated Helicobacter hepaticus
KR19990007828A (ko) * 1995-04-21 1999-01-25 피터 터비 헬리코박터 감염 방어 항원
JP3007037B2 (ja) * 1995-07-19 2000-02-07 秀実 高橋 ヘリコバクター・ピロリ菌ウレアーゼ蛋白由来の人工抗原及びその人工抗原によって誘発された抗体
GB2307987A (en) * 1995-12-06 1997-06-11 Univ Manchester Epitopes of the urease of Helicobacter pylori as dignostic agents; pharmaceuticals comprising such epitopes or the antibodies thereto
JP3430853B2 (ja) * 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
US20030158396A1 (en) * 1997-07-29 2003-08-21 Harold Kleanthous Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
US5985631A (en) * 1997-09-12 1999-11-16 Oravax-Merieux Co. Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
WO2001083531A1 (en) * 2000-04-27 2001-11-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for identifying helicobacter antigens

Also Published As

Publication number Publication date
EP1176192A3 (de) 2002-02-06
AU5432101A (en) 2002-01-24
US7514547B2 (en) 2009-04-07
CA2351110A1 (en) 2002-01-17
US20040005325A1 (en) 2004-01-08
ES2208519T3 (es) 2004-06-16
PT1176192E (pt) 2004-01-30
EP1176192A2 (de) 2002-01-30
DK1176192T3 (da) 2004-02-02
JP2002355054A (ja) 2002-12-10
AU782172B2 (en) 2005-07-07
EP1176192B1 (de) 2003-10-01
DE60100879D1 (de) 2003-11-06
DE60100879T2 (de) 2004-05-19

Similar Documents

Publication Publication Date Title
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
ATE330013T1 (de) Lawsonia intracellularis impfstoff
EA200700849A1 (ru) Первичная/бустерная противомалярийная вакцина
DK0942983T3 (da) Streptococcus pneumoniae-antigener og -vacciner
ATE470673T1 (de) Impfstoffe mit lawsoniaintrazellularis- untereinheit
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
ATE450545T1 (de) Impfstoff mit lawsonia intracellularis- untereinheit
ATE251215T1 (de) Helicobacter felis impfstoff
ZA200602107B (en) Piroplasmid vaccine
WO2004007726A3 (en) Brachyspira hyodysenteriae vaccine
TW200801034A (en) Novel sea lice vaccine
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
DK0995799T3 (da) Coccidiose-vacciner
WO2002051237A3 (en) Helicobacter proteins, nucleic acids and uses thereof
ATE374622T1 (de) Genetische impstoffe mit adjuvans
WO2004024769A3 (en) Ostertagia vaccine
DE60025522D1 (de) Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung
ATE450546T1 (de) Impfstoffe mit ornithobakterium rhinotracheale- untereinheit
TH62170A (th) วัคซีนเชื้อก่อโรค Lawsonia intracellularis
ATE460945T1 (de) Genetische adjuvanz-impfstoffe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1176192

Country of ref document: EP

REN Ceased due to non-payment of the annual fee